½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1519669

POC(Point-of-Care) µ¥ÀÌÅÍ °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå º¸°í¼­ : Á¦°ø ÇüÅÂ, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2024-2032³â)

Point-of-Care Data Management Software Market Report by Mode of Delivery, Application, End User, and Region 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 136 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ POC(Point-of-Care) µ¥ÀÌÅÍ °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 7¾ï 8,640¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2024-2032³â ¼ºÀå·ü(CAGR) 10.54%¸¦ º¸À̸ç, 2032³â¿¡´Â 19¾ï 8,940¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇÏ°í ÀÖ½À´Ï´Ù. ÇコÄɾî IT¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, ½Ç½Ã°£ ȯÀÚ µ¥ÀÌÅÍ¿¡ ´ëÇÑ ¿ä±¸ Áõ°¡, ¼ÒÇÁÆ®¿þ¾î ±â¼ú Áøº¸, ȯÀÚ Á᫐ ÄÉ¾î ½Ç½Ã°£ µ¥ÀÌÅÍ ¾×¼¼½º Á߿伺 Áõ°¡ µîÀÌ POC(Point-of-Care) µ¥ÀÌÅÍ °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå Á¡À¯À²À» ÃËÁøÇÏ´Â ¿äÀÎÀÔ´Ï´Ù.

POC(Point-of-Care) µ¥ÀÌÅÍ °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ºÐ¼® :

ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ È¿À²ÀûÀÎ ÀÇ·á ¼­ºñ½º Á¦°ø¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¸¸¼ºÁúȯ Áõ°¡, ±â¼ú ¹ßÀüÀ¸·Î ÀÎÇØ POC(Point-Of-Care) µ¥ÀÌÅÍ °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ¼ºÀåÀÌ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå µ¿Çâ : Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼ÇÀÇ Ã¤ÅÃ, ÀΰøÁö´É°ú ¸Ó½Å·¯´×ÀÇ ÅëÇÕÀº POC(Point-Of-Care) µ¥ÀÌÅÍ °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ µÎµå·¯Áø Ãß¼¼ÀÔ´Ï´Ù.

Áö¿ªÀû µ¿Çâ : ÀÇ·á ÀÎÇÁ¶ó°¡ Àß °®Ãß¾îÁ® ÀÖ°í ÷´Ü ±â¼ú µµÀÔÀÌ È°¹ßÇÑ ºÏ¹Ì°¡ POC(Point-Of-Care) µ¥ÀÌÅÍ °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ¼ö¿ä¸¦ ÁÖµµÇÏ°í ÀÖ½À´Ï´Ù.

°æÀï ȯ°æ: Abbott Laboratories, Danaher Corporation, Datalink LLC µîÀÌ 2021³â POS(Point-of-Care) µ¥ÀÌÅÍ °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀ» ÁÖµµÇÏ´Â ÁÖ¿ä ±â¾÷ÀÔ´Ï´Ù.

°úÁ¦¿Í ±âȸ: °úÁ¦¿¡´Â µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã, »óÈ£¿î¿ë¼º ¹®Á¦, ±ÔÁ¦ º¹À⼺ µîÀÌ ÀÖÀ¸¸ç, POC(Point-Of-Care) µ¥ÀÌÅÍ °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ºñÁî´Ï½º ±âȸ¿¡´Â ¿ø°ÝÀÇ·á äÅÃ, ½ÅÈï ±¹°¡ ½ÃÀå È®´ë, »ç¿ëÀÚ Ä£È­ÀûÀÎ ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼Ç °³¹ß µîÀÌ ÀÖ½À´Ï´Ù.

POC(Point-of-Care) µ¥ÀÌÅÍ °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå µ¿Çâ :

Point-of-care °Ë»çÀÇ Àαâ Áõ°¡

½Å¼ÓÇÏ°í ºÐ»êµÈ Áø´Ü °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÇöÀåÁø´Ü°Ë»ç(POCT)ÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ´Â ÇöÀåÁø´Ü µ¥ÀÌÅÍ °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå Àü¸ÁÀ» °ßÀÎÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ ¼ÒÇÁÆ®¿þ¾î´Â POCT ÀåºñÀÇ µ¥ÀÌÅ͸¦ ÀüÀÚ ÀÇ·á ±â·Ï(EHR) ¹× °Ë»ç Á¤º¸ ½Ã½ºÅÛ(LIS)¿¡ ÅëÇÕÇÏ´Â µ¥ µµ¿òÀÌ µÇ±â ¶§¹®¿¡ ¼ö¿ä Áõ°¡¸¦ ÃËÁøÇÏ°í ÀÖ½À´Ï´Ù. ȯÀÚ Á᫐ ÀÇ·áÀÇ Á߿伺ÀÌ °­Á¶µÇ°í µ¥ÀÌÅÍ¿¡ ´ëÇÑ ½Ç½Ã°£ Á¢±ÙÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö¸é¼­ ÀÌ ¼ÒÇÁÆ®¿þ¾îÀÇ »ç¿ëÀº ´õ¿í ÇʼöÀûÀÔ´Ï´Ù. ƯÈ÷ ÁßȯÀÚ Ä¡·á ÇöÀå¿¡¼­ Á¤È®ÇÑ È¯ÀÚ Á¤º¸¿¡ Áï°¢ÀûÀ¸·Î Á¢±ÙÇÒ ¼ö ÀÖ´Ù´Â °ÍÀº ¾Æ¹«¸® °­Á¶Çصµ Áö³ªÄ¡Áö ¾ÊÀ» Á¤µµ·Î Áß¿äÇÑ °¡Ä¡´Ù.

±Þ°ÝÇÑ ±â¼ú ¹ßÀü

Ŭ¶ó¿ìµå ÄÄÇ»ÆÃ, µ¥ÀÌÅÍ ºÐ¼® µî ÀÇ·á ±â¼úÀÇ ¹ßÀüÀº Á¤±³ÇÑ ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼ÇÀÇ °³¹ß·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °³¼±Àº ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ POCT ±â±â¸¦ ÅëÇØ ¾òÀº µ¥ÀÌÅ͸¦ º¸´Ù È¿À²ÀûÀ¸·Î °ü¸®ÇÏ°í ºÐ¼®ÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÏ¿© ´õ ³ªÀº ȯÀÚ °ü¸®¿Í ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ¶ÇÇÑ ÀΰøÁö´É(AI), ¸Ó½Å·¯´× µî ÇコÄÉ¾î ºÐ¾ßÀÇ Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀüÀÌ ÀÌ ½ÃÀåÀ» ÁÖµµÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ´Â Áø·á ½ÃÁ¡ µ¥ÀÌÅÍ °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ¸ÅÃâ Àü¸ÁÀ» ¹à°Ô ÇÏ°í ÀÖ½À´Ï´Ù.

¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ°ú ¿ø°ÝÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡

¿ø°ÝÀÇ·á ¼­ºñ½º Áõ°¡¿Í ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¹× °¡»ó Áø·á¸¦ ÃËÁøÇϱâ À§ÇÑ È¿°úÀûÀÎ ±â·Ï °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÃÖ±Ù Áø·á ½ÃÁ¡ µ¥ÀÌÅÍ °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ÃÖ±Ù µ¿ÇâÀº µ¥ÀÌÅÍ °ü¸® ¼Ö·ç¼ÇÀ» Æ÷ÇÔÇÏ¿© ´Ù¾çÇØÁö°í ÀÖ½À´Ï´Ù. ÀÌ ¼ÒÇÁÆ®¿þ¾î´Â ¿ø°ÝÁö¿¡¼­ ȯÀÚ Á¤º¸¿¡ ¾×¼¼½ºÇÏ°í, È°·Â ¡Èĸ¦ ¸ð´ÏÅ͸µÇÏ°í, ȯÀÚ°¡ ¾îµð¿¡ ÀÖµç ½Ç½Ã°£À¸·Î Ä¡·á¸¦ ÃßÀûÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. À̸¦ ÅëÇØ Áø·á¿Í ÀÔ¿øÀ» ÃÖ¼ÒÈ­ÇÏ°í ÀÇ·á ¼­ºñ½º Á¦°øÀÇ È¿À²¼ºÀ» ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·á°¡ È®´ëµÉ °ÍÀ¸·Î ¿¹»óµÊ¿¡ µû¶ó ÷´Ü Áø·á µ¥ÀÌÅÍ °ü¸® ¼ÒÇÁÆ®¿þ¾î¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ´Â Áø·á ½ÃÁ¡ µ¥ÀÌÅÍ °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ °¡°ÝÀ» »ó½Â½Ãų °ÍÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»ç ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • º¸ÅÒ¾÷ Á¢±Ù
    • Åé´Ù¿î Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ¼­·Ð

  • °³¿ä
  • ÁÖ¿ä ¾÷°è µ¿Çâ

Á¦5Àå ¼¼°èÀÇ POC(Point-of-Care) µ¥ÀÌÅÍ °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ³»¿ª : Á¦°ø Çüź°

  • Ŭ¶ó¿ìµå ±â¹Ý
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ¿ÂÇÁ·¹¹Ì½º
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦7Àå ½ÃÀå ³»¿ª : ¿ëµµº°

  • °¨¿°Áõ ´ëÃ¥ ±â±â
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • Ç÷´ç ¸ð´ÏÅ͸µ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ÀÀ°í ¸ð´ÏÅ͸µ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ¿ä°Ë»ç
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ½ÉÀå ´ë»ç ¸ð´ÏÅ͸µ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ¾Ï¸¶Ä¿
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • Ç÷¾×ÇÐ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±âŸ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦8Àå ½ÃÀå ³»¿ª : ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø/ÁýÁß Ä¡·á½Ç
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • Áø´Ü ¼¾ÅÍ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • Ŭ¸®´Ð/¿Ü·¡
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦9Àå ½ÃÀå ³»¿ª : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ³»¿ª : ±¹°¡º°
    • ½ÃÀå ¿¹Ãø

Á¦10Àå ÃËÁø¿äÀΡ¤¾ïÁ¦¿äÀΡ¤±âȸ

  • °³¿ä
  • ÃËÁø¿äÀÎ
  • ¾ïÁ¦¿äÀÎ
  • ±âȸ

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ¹ÙÀ̾îÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • °æÀïÀÇ Á¤µµ
  • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦13Àå °¡°Ý ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ÀÇ °³¿ä
    • Abbott Laboratories
    • Danaher Corporation
    • Datalink LLC
    • Orchard Software Corporation
    • Randox Laboratories Ltd.
    • Roche Holding AG
    • Siemens Healthineers AG(Siemens AG)
    • TELCOR Inc.
KSA 24.07.30

The global point-of-care data management software market size reached US$ 786.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,989.4 Million by 2032, exhibiting a growth rate (CAGR) of 10.54% during 2024-2032. The increasing investments in healthcare IT, the rising need for real-time patient data, the advancements in software technology, and the growing importance of real-time data access for patient-centered care are some of the factors propelling the point-of-care data management software market share.

Point-of-care Data Management Software Market Analysis:

Major Market Drivers: Increasing demand for efficient healthcare delivery, rise in chronic diseases, and advancements in technology drive the point-of-care data management software market growth.

Key Market Trends: Adoption of cloud-based solutions and integration of artificial intelligence and machine learning are prominent point-of-care data management software market trends.

Geographical Trends: North America dominates the point-of-care data management software market demand due to well-established healthcare infrastructure and high adoption of advanced technologies.

Competitive Landscape: Abbott Laboratories, Danaher Corporation, Datalink LLC, etc. are some of the key players driving the point-of-care data management software market 2021.

Challenges and Opportunities: Challenges include data privacy concerns, interoperability issues, and regulatory complexities, while point-of-care data management software market opportunities lie in the adoption of telemedicine, expansion in emerging markets, and development of user-friendly software solutions.

Point-of-care Data Management Software Market Trends:

Increasing popularity of point of care testing

The adoption of POCT is on the rise as the demand for fast and decentralized diagnostic tests keeps growing. This, in turn, is driving point-of-care data management software market outlook. This software helps bring together data from POCT devices into electronic health records (EHRs) or laboratory information systems (LIS), hence promoting the growth in its demand. It is more imperative now to use this software due to increased focus in patient-centered care and a need for real time access to data. The value of having immediate access to accurate patient information especially in critical care settings cannot be overemphasized.

Rapid technological advancements

Advancement in medical technology including cloud computing and data analytics, among others has also led to sophisticated software solutions development. These improvements facilitate efficient management and analysis of data obtained through POCT devices by healthcare providers leading to better patient care and decision-making. Furthermore, continued technological advancements in healthcare sector such as AI incorporation and machine learning are driving this market. This, in turn, is creating a positive outlook for the point-of-care data management software market revenue.

Growing focus on remote patient monitoring and telemedicine

A rise in telehealth services and an increasing need for effective records management solutions to facilitate remote patient monitoring and virtual consultations has led to various point-of-care data management software market recent developments, including data management solutions. The software helps to remotely access patient information, monitor their vital signs, and follow up treatments in real-time irrespective of where patients are. This increases the efficiency of healthcare delivery by minimizing physical visits and hospitalizations. The predicted expansion of telemedicine would grow the need for sophisticated point-of-care data management software. This, in turn, will drive the point-of-care data management software market price.

Point-of-care Data Management Software Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on mode of delivery, application, and end user.

Breakup by Mode of Delivery:

Cloud-Based

On-premises

Cloud-based accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the mode of delivery. This includes cloud-based and on-premises. According to the report, cloud-based represented the largest segment.

The prevalence of cloud-based delivery in the Point-of-Care Data Management Software Market arises from its inherent benefits such as scalability, accessibility and cost-effectiveness. This eventually allows healthcare professionals to access patient's information remotely thus enabling remote patient monitoring through telemedicine. Moreover, cloud infrastructure is highly scalable thereby allowing easy integration with existing systems and taking care of increased data volumes without high capital investments. Subsequently, cloud solutions are also very affordable because they have a subscription-based pricing model which avoids up-front costs reducing total ownership expenses for better health management.

Breakup by Application:

Infectious Disease Devices

Glucose Monitoring

Coagulation Monitoring

Urinalysis

Cardiometabolic Monitoring

Cancer Markers

Hematology

Others

Glucose monitoring holds the largest share of the industry

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes infectious disease devices, glucose monitoring, coagulation monitoring, urinalysis, cardiometabolic monitoring, cancer markers, hematology, and others. According to the report, glucose monitoring accounted for the largest market share.

The reason why glucose monitoring dominates the market is as it plays a crucial role in diabetes management which has become a global health burden. Given the growing prevalence of diabetes and an increasing demand for continuous glucose monitoring devices, there has been an increase in need for effective data management solutions. POC data management software facilitates seamless integration of CGM glucose data into electronic health records and enables real-time blood sugar level tracking according to point-of-care data management software market statistics.

Breakup by End User:

Hospitals/Critical Care Units

Diagnostic Centers

Clinics/Outpatient

Hospitals/critical care units represent the leading market segment

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals/critical care units, diagnostic centers, and clinics/outpatient. According to the report, hospitals/critical care units represented the largest segment.

Hospitals and critical care units play a role in the market as they rely on accurate patient data to make informed decisions. These healthcare facilities need solutions for managing data to handle a variety of diagnostic tests and medical procedures conducted at the point of care. Point of care software for managing data helps in integrating test results patient details and treatment plans into health records (EHRs) which improves workflow efficiency and coordination of patient care. Additionally, this software allows healthcare professionals to access information, in real time enabling them to closely monitor patient conditions optimize treatment approaches and enhance clinical outcomes.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest point-of-care data management software market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share

In the Point of Care Data Management Software Market North America takes the lead, for reasons. The region has a healthcare system that widely uses health records (EHRs) and advanced medical technologies. Secondly the presence of market players and active research and development efforts innovation and product improvements. Additionally, government support for healthcare solutions and increased healthcare spending also play a role in driving market growth. Furthermore, healthcare providers and patients in North America are well informed about the advantages of point of care data management software, which boosts its adoption. The projected growth of the hospitals market in North America to reach a revenue of US$1,585.00 billion by 2024 is a significant driver for market growth. As the hospitals market expands, there will be a surge in demand for healthcare services, including diagnostic procedures, treatments, and patient management. This increased demand necessitates efficient data management solutions to handle the growing volume of patient information and streamline workflows. Overall, these factors establish North America as a leading market.

Leading Key Players in the Point-of-care Data Management Software Industry:

Strategic partnerships, acquisitions, and product innovations by key players are key growth drivers. In line with this, these players cooperate with healthcare institutions, technology companies as well as research organizations thereby expanding their market reach and enhancing their offerings. Moreover, some major players acquire smaller specialized software firms leading to a wider range of products within the same firm while capturing niche markets. They also make continuous R&D investments that allow them to anticipate emerging trends and keep pace with technological changes in order to offer advanced customer-oriented products.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

Danaher Corporation

Datalink LLC

Orchard Software Corporation

Randox Laboratories Ltd.

Roche Holding AG

Siemens Healthineers AG (Siemens AG)

TELCOR Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Latest News:

April 2, 2024: Abbott Laboratories received FDA approval for TriClip(TM) transcatheter edge-to-edge repair (TEER) system that's specifically designed for the treatment of tricuspid regurgitation (TR), or a leaky tricuspid valve.

February 5, 2024: Danaher Corporation launched a strategic collaboration with Cincinnati Children's Hospital Medical Center to improve patient safety by addressing a leading cause of failure in clinical trials.

March 18, 2024: Datalink LLC announced new medical chart review solutions to support risk adjustment and HEDIS quality performance.

Key Questions Answered in This Report:

  • How has the global point-of-care data management software market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global point-of-care data management software market?
  • What is the impact of each driver, restraint, and opportunity on the global point-of-care data management software market?
  • How big is the point-of-care data management software market?
  • Who is the largest region in point-of-care data management software market?
  • What are the key regional markets?
  • Which countries represent the most attractive point-of-care data management software market?
  • What is the breakup of the market based on the mode of delivery?
  • Which is the most attractive mode of delivery in the point-of-care data management software market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the point-of-care data management software market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the point-of-care data management software market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global point-of-care data management software market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Point-of-Care Data Management Software Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Mode of Delivery

  • 6.1 Cloud Based
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 On-premises
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Infectious Disease Devices
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Glucose Monitoring
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Coagulation Monitoring
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Urinalysis
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Cardiometabolic Monitoring
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Cancer Markers
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Hematology
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Others
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals/Critical Care Units
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Clinics/Outpatient
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Danaher Corporation
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Datalink LLC
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Orchard Software Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Randox Laboratories Ltd.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Roche Holding AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Siemens Healthineers AG (Siemens AG)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 TELCOR Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦